Search
for

    Sort by

    Research 19

    1. Nonscarring Alopecia in Adults Treated With GLP ‐1s: A Propensity Score Matched TriNetX Cohort Study The Laryngoscope · 2026
    2. EFLÚVIO TELÓGENO ASSOCIADO AO USO DE MEDICAMENTOS EMAGRECEDORES: MECANISMOS FISIOPATOLÓGICOS E EVIDÊNCIAS CLÍNICAS Revista Ibero-Americana de Humanidades, Ciências e Educação · 2026
    3. 0439 Temporal–phenotype signatures of alopecia associated with GLP-1–based therapies: A PRISMA-ScR scoping review Journal of Investigative Dermatology · 2026
    4. 76708 Risk of Developing Scarring and Non-Scarring Alopecia with GLP-1 and GLP-1/GIP Agonist Utilization Journal of the American Academy of Dermatology · 2026
    5. Hair Loss in Patients on Glucagon-Like Peptide 1 Receptor Agonists: Understanding Risks and Managing Outcomes Dermatology and Therapy · 2026
    6. Incretin-Based Drugs for Obesity: Common and Drug-Specific Reporting Patterns of Adverse Drug Reactions—A Comparative Disproportionality Analysis Using EudraVigilance Reports Integrating SmPC Data Pharmaceuticals · 2026
    7. GLP-1 therapies and hair loss: A systematic review of current evidence and implications for counseling Science Progress · 2026
    8. Telogen Effluvium and Metabolic Stress in Modern Weight Loss Interventions: A Narrative Clinical Review Brazilian Journal of Hair Health · 2025
    9. GLP-1 e Estética: Ozempic Face, Flacidez e Recuperação Open MIND · 2026
    10. Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons Dermatology and Therapy · 2025 · 1 citations
    11. Farmácia Boa Hora - Porto Open Repository of the University of Porto (University of Porto) · 2025
    12. Exploring Herbal Alternatives to Pharmaceutical Treatments for Polycystic Ovary Syndrome 2025
    13. Farmácia Sanches - Leiria e nos Serviços Farmacêuticos do Hospital Lusíadas - Porto Open Repository of the University of Porto (University of Porto) · 2025
    14. Cutaneous and Mucosal Manifestations Associated with Celiac Disease Nutrients · 2018 · 57 citations
    15. New-Onset Alopecia Is Significantly Higher with Tirzepatide than with Semaglutide, Even After Weight-Loss Matching Preprints.org · 2026
    16. Associations Between GLP‐1 Receptor Agonists and Alopecia: A Multi‐Centre Retrospective Analysis and Public Interest Trends JEADV Clinical Practice · 2025
    17. Dermatological adverse reactions and therapeutic potential of semaglutide, liraglutide and tirzepatide: Analysis of UK pharmacovigilance data and literature review 2025 · 1 citations
    18. Dermatological, Trichological and Quality of Life Consequences of GLP ‐1 Receptor Agonist‐Mediated Weight Loss: A US Cross‐Sectional Survey Journal of Cosmetic Dermatology · 2026
    19. Effects of Glucagon-like Peptide-1 Receptor Agonists on Skin Homeostasis and Skin Aging Processes Journal of Clinical Medicine · 2026